Yuyu Pharma, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 0.00002 million compared to negative sales of KRW 0.00002 million a year ago. Net income was KRW 96.11 million compared to net loss of KRW 293.15 million a year ago.

Basic earnings per share from continuing operations was KRW 2 compared to basic loss per share from continuing operations of KRW 22 a year ago. Diluted earnings per share from continuing operations was KRW 2 compared to diluted loss per share from continuing operations of KRW 22 a year ago. Basic earnings per share was KRW 2 compared to basic loss per share of KRW 22 a year ago.